Full-Time

Scientist I/II

Hplc MS

Confirmed live in the last 24 hours

Tessera Therapeutics

Tessera Therapeutics

201-500 employees

Develops gene editing technology for genetic medicine

Biotechnology
Healthcare

Mid, Senior

Cambridge, MA, USA

Category
Lab & Research
Life Sciences
Medical Research
Required Skills
Data Analysis
Requirements
  • BS in analytical chemistry, biochemistry, or relevant discipline with 8+ years of relevant experience, or M.S. with 6+ years relevant industry experience, or PhD with 1+ years industry experience.
  • The application of a diverse set of analytical assays, with strong background in LC-MS (required) and HPLC.
  • RNA or Oligonucleotide analytical chemistry and biophysical techniques (required), preferably in biopharmaceutically relevant systems.
  • Analyzing and interpreting written material, in various forms including tables and spreadsheets, as well as quantitative and qualitative data.
  • Writing clear and concise reports and memos.
  • A high level of personal and spatial organization.
  • Strong interpersonal and communication skills.
  • A learning and betterment mindset.
Responsibilities
  • Advancing existing and establishing new methods using mass spectrometry, HPLC and electrophoretic methods to characterize RNA molecules (oligos and/or mRNA).
  • Representing the Analytical Development team in cross-functional meetings, presenting results and providing scientific input as needed.
  • Participating in in-depth investigations, including orthogonal method evaluation, understanding RNA and oligonucleotide stability, and characterizing impurities in a CMC setting.
  • Exploring new technology and software to strengthen and streamline RNA and oligonucleotide characterization workflows.
  • Maintaining external awareness of advances in the field through keeping updated on relevant publications, attending conferences and workshops.
  • Effectively collaborating within the Analytical team and with other functional teams.
  • Using scientific and technical expertise for instrument maintenance and troubleshooting.
  • Training and mentoring junior scientists as needed.
  • Performing assays, analyzing, interpreting, and reporting results in appropriate format (ELN, analytical reports, and presentations).
  • Performing additional duties and responsibilities as required.

Tessera Therapeutics focuses on genetic medicine, specifically through a technology called Gene Writing, which enables precise modifications to the human genome. This technology allows for permanent changes to genetic material in any cell, aiming to cure diseases at their source. Tessera's Gene Writing can perform both small and large genetic alterations, making it applicable to a wide range of genetic disorders. The company collaborates with research institutions, pharmaceutical companies, and healthcare providers to develop new treatments. Tessera generates revenue through partnerships, licensing agreements, and the potential sale of its technology. With significant funding secured, Tessera aims to advance its platform and fulfill its goal of curing diseases by rewriting genetic code.

Company Stage

Series C

Total Funding

$518.2M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

-8%

1 year growth

-10%

2 year growth

14%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tessera's innovative Gene Writing technology has the potential to cure previously untreatable genetic conditions, offering a transformative impact on healthcare.
  • The company's strategic partnerships and licensing agreements with major pharmaceutical firms and research institutions can drive significant revenue growth and market penetration.
  • Recent leadership appointments, including a new General Counsel and Chief Regulatory Officer, bring extensive industry experience that can guide the company through regulatory and commercial milestones.

What critics are saying

  • The highly competitive biotechnology sector requires continuous innovation to maintain Tessera's market position.
  • Regulatory hurdles and the complexity of clinical trials for genetic therapies could delay product development and commercialization.

What makes Tessera Therapeutics unique

  • Tessera Therapeutics' Gene Writing technology offers a unique capability to make precise and permanent genetic alterations, setting it apart from traditional gene editing methods.
  • The company's focus on a wide range of genetic disorders, from phenylketonuria to sickle cell disease, showcases the versatility and broad applicability of its platform.
  • Securing $300 million in Series C financing highlights strong investor confidence and provides substantial resources for advancing their groundbreaking technology.

Help us improve and share your feedback! Did you find this helpful?